A detailed history of Td Asset Management Inc transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 694,722 shares of SMMT stock, worth $13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
694,722
Previous 266,800 160.39%
Holding current value
$13 Million
Previous $2.08 Million 631.09%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$6.89 - $31.93 $2.95 Million - $13.7 Million
427,922 Added 160.39%
694,722 $15.2 Million
Q2 2024

Aug 02, 2024

BUY
$2.39 - $10.92 $637,652 - $2.91 Million
266,800 New
266,800 $2.08 Million

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.76B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.